US 11154601
Cancer vaccines targeting BORIS and uses thereof
granted A61KA61K2039/5154A61K2039/5156
Quick answer
US patent 11154601 (Cancer vaccines targeting BORIS and uses thereof) held by Inovio Pharmaceuticals, Inc. expires Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Inovio Pharmaceuticals, Inc.
- Grant date
- Tue Oct 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K2039/5154, A61K2039/5156, A61K2039/5158, A61K2039/53